Epilepsy Intractable Clinical Trial
Verified date | December 2016 |
Source | Tehran University of Medical Sciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Epilepsy is one of a common neurological disorder. Antiepileptic drugs (AEDs) are usually the primary treatment of epilepsy. However, almost 30% of patients do not respond to AEDs and other treatments including ketogenic diet (KD) are used. The Ketogenic Diet (KD) is a low-carbohydrate, high fat, adequate-protein diet. In this study, investigators are going to compare two kinds of the ketogenic diet namely classical ketogenic diet and modified Atkins diet. Fifty children and adolescents with intractable epilepsy will be included, 25 patients in each group, and will receive the diet for three months on non-randomised basis. In the classical ketogenic diet, the diet with a ratio of 4 to 1 (4:1), each 4 grams of fat to each gram of carbohydrate plus protein, will be introduced. Classical ketogenic diet will be established on outpatient setting, without fasting and gradually. The modified Atkins diet will be applied by the ratio of 1:1 or 2:1, each 1 or 2 grams of fat to each gram of carbohydrate plus protein.
Status | Completed |
Enrollment | 50 |
Est. completion date | May 2017 |
Est. primary completion date | April 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 1 Year to 18 Years |
Eligibility |
Inclusion Criteria: - Children and adolescents age 1 to 18 years Have not responded well to at least two primary and one secondary antiepileptic drugs Have not received ketogenic diet therapy previously Absence of renal diseases history Absence of cardiovascular diseases history Absence of thyroid function disorders history Absence of cholesterol level more than 300 mg/dl and Triglyceride level more than 200 mg/dl Absence of inherited metabolic disorders that are contraindicated for ketogenic diet therapy including fatty acid oxidation disorders Exclusion Criteria: - Onset of complications that threat the life of the patient Inability to continue the diet Unwillingness to adhere the diet |
Country | Name | City | State |
---|---|---|---|
Iran, Islamic Republic of | Childrens' Medical Center, Tehran University of Medical Sciences | Tehran |
Lead Sponsor | Collaborator |
---|---|
Tehran University of Medical Sciences |
Iran, Islamic Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Comparison of the efficacy of the outpatient classical ketogenic diet and modified atkins diet | Prior to and three months after initiation of the classical ketogenic diet and modified Atkins diet | ||
Secondary | Comparison of the nutritional status of children and adolescents on the classical KD and MAD | Baseline and three months after initiation of the classical ketogenic diet and modified Atkins diet | ||
Secondary | Comparison of the lipid profiles of children and adolescents on the classical KD and MAD | Baseline and three months after initiation of the classical ketogenic diet and modified Atkins diet | ||
Secondary | Comparison of the serum electrolytes levels of children and adolescents on the classical KD and MAD | Baseline and three months after initiation of the classical ketogenic diet and modified Atkins diet |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03790436 -
Betaquik as an Adjunct to Dietary Management of Epilepsy in Adults on the Modified Atkins Diet
|
N/A | |
Completed |
NCT05503511 -
Safety and Pharmacokinetic Study of NPT 2042 Soft-gelatin Capsules Administered Orally to Healthy Adult Subjects
|
Phase 1 | |
Enrolling by invitation |
NCT04286776 -
Memory Retrieval and Encoding Investigated by Neural Stimulation
|
N/A | |
Completed |
NCT04763070 -
Ciprofloxacin in Drug-resistant Epilepsy
|
N/A | |
Completed |
NCT03403907 -
The Effect of Probiotic Supplementation in Drug-resistant Epilepsy Patients
|
N/A | |
Recruiting |
NCT04158531 -
REC2Stim as a Treatment for Refractory Epilepsy in the Primary Sensorimotor Cortex.
|
N/A | |
Recruiting |
NCT03289572 -
Microgrid II - Electrocorticography Signals for Human Hand Prosthetics
|
||
Enrolling by invitation |
NCT05332990 -
Multicenter Comparison of Interictal HFO as a Predictor of Seizure Freedom
|
||
Recruiting |
NCT04325360 -
Effects of Transcranial Direct Current Stimulation (tDCS) for the Treatment of Refractory Epilepsy
|
N/A | |
Active, not recruiting |
NCT05727943 -
Add-on Clioquinol in Drug-resistant Childhood Epilepsy: an Exploratory Study
|
Phase 2 | |
Recruiting |
NCT04649008 -
Localizing Epileptic Networks Using MRI and iEEG
|
Early Phase 1 | |
Active, not recruiting |
NCT03916848 -
Novel Network Analysis of Intracranial Stereoelectroencephalography
|
N/A | |
Completed |
NCT03646240 -
ABI-009 (Nab-rapamycin) for Surgically-Refractory Epilepsy (RaSuRE)
|
Phase 1 | |
Recruiting |
NCT03857074 -
Effects of Green Light Exposure on Epileptic Spikes in Patients With Refractory Epilepsy
|
N/A | |
Enrolling by invitation |
NCT03702127 -
TMS - Intracranial Electrodes
|
N/A | |
Recruiting |
NCT05015868 -
Contribution of Genetics, Non-invasive Methods and Neuropsychology in Focal Cryptogenic Epilepsies
|
N/A | |
Enrolling by invitation |
NCT06138808 -
5-SENSE Score Validation Study
|
||
Not yet recruiting |
NCT03741192 -
Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patient's Refractory to AEDs
|
N/A | |
Enrolling by invitation |
NCT05248269 -
Thermocoagulation in Drug Resistant Focal Epilepsy
|
N/A | |
Completed |
NCT04399954 -
Evaluation of Ketoflo
|
N/A |